Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NDoC Pacer 8-29-13 HTC TPL royalty rate/s determination/discus...

BUT still, this is a highly telling document, and it basically says to me that TPL will accept $10M from HTC for all past 336 & 890 infringments, and a license for any future use.

This is OUR valuation and damages expert. How could he make the statement portion bolded below, without first hand knowledge of current Party discussions ??

"115. For HTC the amount of the lump sum payment the parties would agree to based on the above royalty rate and royalty base [actual rate/base is redacted] is $10 million".

Share
New Message
Please login to post a reply